Prostate cancer may progress silently for a long time and is often suspected through PSA changes, examination findings or MRI results. At ReSurgeClinic in Kyrenia / Cyprus, the aim is not to create fear from every PSA rise, but to evaluate risk correctly, plan MRI or biopsy when needed and choose the right follow-up or treatment path for the individual patient.
The main complaint, duration of symptoms, previous treatments, accompanying diseases, medications, expectations and relevant examination findings are evaluated together.
Clinical focus
The aim is not to apply the same treatment to every patient, but to understand the underlying mechanism and choose the safest suitable step.
Treatment logic
Follow-up, medical treatment, minimally invasive procedures or surgery are discussed step by step according to the patient’s condition.
Detailed information
What would you like to learn about?
Select a topic to open only the information you need.
When should prostate cancer be suspected?
Prostate cancer may not cause symptoms in the early period. PSA elevation, abnormal examination, family history or suspicious MRI findings can raise suspicion.
A single PSA value is not enough by itself; age, prostate size, previous PSA values and risk factors should be considered.
How are PSA and MRI interpreted?
PSA can be affected by BPH, infection or procedures, but persistent elevation or concerning trend requires structured evaluation.
Multiparametric prostate MRI helps identify suspicious areas and supports the biopsy decision in selected patients.
When is biopsy needed?
When risk remains significant after PSA, examination and MRI assessment, prostate biopsy may be recommended. MRI fusion biopsy allows targeted sampling of suspicious areas when appropriate.
The aim is to avoid unnecessary biopsy while not delaying diagnosis in patients who need it.
How is the next step decided?
If cancer is diagnosed, grade, extent, PSA, MRI and patient characteristics are evaluated together.
Active surveillance, surgery, radiotherapy or other treatments are discussed according to the risk group and patient expectations.
Treatments and procedures
PSA and examination
Risk is assessed using PSA trend, examination and patient-specific factors.
Prostate MRI
MRI helps identify suspicious lesions and plan targeted biopsy if needed.
Fusion biopsy
Targeted sampling may increase diagnostic clarity in selected patients.
Risk-based follow-up
Follow-up or treatment is planned according to pathology and risk group.
Frequently asked questions
Does every PSA elevation mean cancer?
No. PSA can rise for many reasons, but persistent or unexplained elevation needs evaluation.
Can MRI replace biopsy?
MRI is helpful, but tissue diagnosis may be required for definitive diagnosis.
Is every prostate cancer treated immediately?
No. Some low-risk cancers may be followed with active surveillance; the decision depends on risk.
